Alfedent
The computed 12-month bankruptcy probability of Alfedent is 0.2% (very low). The 2024 annual accounts show equity of €169k and a net result of €57k. Equity is growing by ~49.3% per year across the filed fiscal years. Its solvency ranks better than 95% of 6573 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €169k |
| Net result | €57k |
| Better than sector | 95% |
| Active | 4 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 96.5% | 66.7% | |
| Net result | €57k | €46k | |
| Equity | €169k | €79k | |
| Gross operating margin | €80k | €78k | |
| Total assets | €175k | €154k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €79k |
| Net profit | €57k |
| Cash flow | €65k |
| Staff costs | - |
| Income taxes | €15k |
| Dividends | - |
| Total assets | €175k |
| Equity | €169k |
| Debt | €6k |
| of which ≤ 1y | €6k |
| of which > 1y | - |
| Working capital | €142k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 23.83 |
| Quick ratio | 23.83 |
| Working capital ratio | 81.0% |
| Solvency | 96.5% |
| Debt / equity | 0.04 |
| Long-term debt ratio | - |
| Interest coverage | 1757.83 |
| Gross margin | - |
| Net margin | - |
| ROA | 32.8% |
| ROE | 34.0% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €175k |
| Fixed assets | 21/28 | €27k |
| Tangible fixed assets | 22/27 | €27k |
| Current assets | 29/58 | €148k |
| Amounts receivable within one year | 40/41 | €29k |
| Investments | 50/53 | €48k |
| Cash & bank | 54/58 | €71k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €175k |
| Equity | 10/15 | €169k |
| Contributions / capital | 10/11 | €10k |
| Accumulated profits (losses) | 14 | €159k |
| Amounts payable | 17/49 | €6k |
| Amounts payable within one year | 42/48 | €6k |
| Trade debts payable within one year | 44 | €4k |
| Income statement | ||
| Gross operating margin | 9900 | €80k |
| Operating result | 9901 | €72k |
| Financial income | 75 | €9 |
| Financial charges | 65 | €45 |
| Result before taxes | 9903 | €72k |
| Income taxes | 67/77 | €15k |
| Net result for the period | 9904 | €57k |
| Result to be appropriated | 9905 | €57k |
| NACE primary | Human health(86230) |
| Legal form | Private limited company(610) |
| Incorporation | 24-02-2022 |
| Status | Active |
| Postal code | 2980 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11017A0279/00F000 | Flanders | 1,559 m² | 1 · 204 m² | 9.3 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
22-04-2025 Registered office moved to Zoersel
- Orchideeënlaan 11 te 2980 Zoersel
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Orchidee\u00EBnlaan 11 te 2980 Zoersel",
"city": "Zoersel",
"region": "vlaams_gewest",
"street": "Orchidee\u00EBnlaan",
"country": "BE",
"postcode": "2980",
"box_number": null,
"street_number": "11",
"locality_suffix": null
},
"old_address": null,
"effective_date": "2024-11-05",
"evidence_quote": "Uit het verslag van de bestuurder van 5 november 2024 blijkt dat de maatschappelijke zetel van de vennootschap wordt verplaatst naar de Orchidee\u00EBnlaan 11 te 2980 Zoersel vanaf 5 november 2024.",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "inferred",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-04-22",
"filing_date": "2024-11-05",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"date": "2024-11-05",
"unanimous": null
},
"subject_company": {
"kbo": "0782.577.489",
"name_full": null,
"legal_form": "BV",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Line Cuypers",
"org_rep_person_name": null,
"person_role_at_subject": "Bestuurder"
},
"co_filed_documents": [
"Bijlagen bij-het Belgisch Staatsblad-22/04/2025-Annexes du Moniteur belge"
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Alfedent |